Nanjing, China

Mark Zhiqing MA

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Biosion, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark Zhiqing MA. Retrieved from https://idiyas.com/inventor/mark-zhiqing-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 3.6

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mark Zhiqing Ma: Innovator in Antibody Research

Introduction

Mark Zhiqing Ma is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

Mark Zhiqing Ma holds a patent titled "Antibodies Binding CD40 and Uses Thereof." This patent reflects his research and development efforts in creating antibodies that target CD40, which has important implications for therapeutic applications in immunology.

Career Highlights

Mark is currently employed at Biosion, Inc., a company known for its focus on biopharmaceutical development. His role at the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.

Collaborations

Throughout his career, Mark has worked alongside notable colleagues, including Jinyu Liu and Zhengping Zhang. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Mark Zhiqing Ma is a dedicated inventor whose work in antibody research is paving the way for new therapeutic solutions. His contributions to the field are invaluable, and his ongoing efforts at Biosion, Inc. continue to inspire advancements in biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…